Synendos Therapeutics AG

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

Renaldee is bringing the first natural active form of Vit. D (1,25-dihydroxyvitamin D3) into a human pharma market extracted entirely from a plant, solanum glaucophyllum. Our offering is not to be confused with the inactive form of Vit. D which you can buy over the counter.